Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (101-110 of 368) with videos related to

Pageof 37
Sort By:
Drug and Alcohol Review|April 14, 2026
Factors Associated With Adult Incarceration Among People With Opioid Use Disorder in New South Wales, AustraliaChristel Macdonald, Chrianna Bharat, Louisa Degenhardt, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
Drug and Alcohol Dependence|October 4, 2021
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare systemDaisy Gibbs, Olivia Price, Jason Grebely, et al.
The International Journal on Drug Policy|October 29, 2025
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep studyChloe Montague, Rugiatu Bah, Yumi Sheehan, et al.
Drug and Alcohol Dependence|December 1, 2019
Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, CanadaEmmanuel Fortier, Marie-Pierre Sylvestre, Andreea Adelina Artenie, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimationVincent Montoya, Andrea D Olmstead, Naveed Z Janjua, et al.
The International Journal on Drug Policy|February 21, 2015
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaCarla Treloar, Jake Rance, Nicky Bath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2024
Hepatitis C treatment outcome among people in prison: The SToP-C studyHannah Ryan, Gregory J Dore, Jason Grebely, et al.
Plos One|September 16, 2021
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complicationsJisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, et al.
The Medical Journal of Australia|August 4, 2021
Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment programFergus Stafford, Gregory J Dore, Shawn Clackett, et al.
Pageof 37

Showing results (101-110 of 368) with videos related to

Sort By:
Pageof 37
Drug and Alcohol Review|April 14, 2026
Factors Associated With Adult Incarceration Among People With Opioid Use Disorder in New South Wales, AustraliaChristel Macdonald, Chrianna Bharat, Louisa Degenhardt, et al.
Expert Review of Molecular Diagnostics|January 4, 2024
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?Jason Grebely, Susan Matthews, Louise M Causer, et al.
Drug and Alcohol Dependence|October 4, 2021
Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare systemDaisy Gibbs, Olivia Price, Jason Grebely, et al.
The International Journal on Drug Policy|October 29, 2025
Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep studyChloe Montague, Rugiatu Bah, Yumi Sheehan, et al.
Drug and Alcohol Dependence|December 1, 2019
Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, CanadaEmmanuel Fortier, Marie-Pierre Sylvestre, Andreea Adelina Artenie, et al.
Hepatology (Baltimore, Md.)|February 4, 2015
Differentiation of acute from chronic hepatitis C virus infection by nonstructural 5B deep sequencing: a population-level tool for incidence estimationVincent Montoya, Andrea D Olmstead, Naveed Z Janjua, et al.
The International Journal on Drug Policy|February 21, 2015
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaCarla Treloar, Jake Rance, Nicky Bath, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2024
Hepatitis C treatment outcome among people in prison: The SToP-C studyHannah Ryan, Gregory J Dore, Jason Grebely, et al.
Plos One|September 16, 2021
Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complicationsJisoo A Kwon, Gregory J Dore, Behzad Hajarizadeh, et al.
The Medical Journal of Australia|August 4, 2021
Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment programFergus Stafford, Gregory J Dore, Shawn Clackett, et al.
Pageof 37